United States — Food and Drug Administration & Lawrence Rosen
19 shared events · Importance 3 · Last updated Aug 22, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration issued safety warnings concerning serious neurological complications in dogs related to Zoetis' Bedinvetmab, contributing to its weakening adoption.
Lawrence Rosen: Lawrence Rosen is a founding partner of Rosen Law Firm, recognized for his work in securities class actions, and is involved in the firm's efforts regarding the Zoetis lawsuit.
May 18, 2026 · 316 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration issued a Complete Response Letter to Aldeyra Therapeutics, citing a lack of substantial evidence for the efficacy of reproxalap, which triggered the stock price drop and subsequent lawsuits.
Lawrence Rosen: Lawrence Rosen, a founding partner of Rosen Law Firm, is mentioned as a key figure in the firm's success in securities class actions, which is handling the lawsuit against Aldeyra Therapeutics.
Apr 24, 2026 · 80 articles
Regulatory
United States — Food and Drug Administration: The United States — Food and Drug Administration issued a Complete Response Letter to Disc Medicine, Inc. regarding its bitopertin program, citing uncertainties in the new drug application.
Lawrence Rosen: Lawrence Rosen>>> is a founding partner of Rosen Law Firm>>> and is mentioned for his firm's track record in securities class actions.
Apr 29, 2026 · 68 articles
Regulatory
United States — Food and Drug Administration: Regulator whose briefing documents and advisory committee vote triggered the stock collapse and legal actions.
Lawrence Rosen: Partner at Rosen Law Firm involved in the lawsuit.
Jul 27, 2026 · 293 articles
Regulatory
United States — Food and Drug Administration: The United States — Food and Drug Administration issued a warning letter to ImmunityBio regarding misleading efficacy claims made by Patrick Soon-Shiong about Anktiva, which triggered the stock price drop and subsequent lawsuits.
Lawrence Rosen: Lawrence Rosen is a founding partner of Rosen Law Firm, which is actively involved in the securities class action against ImmunityBio.
Apr 02, 2026 · 132 articles
Regulatory
United States — Food and Drug Administration: The FDA issued safety warnings about neurological complications in dogs from Zoetis' Librela, which contributed to the alleged decline in prescriptions.
Lawrence Rosen: Lawrence Rosen is the founding partner of Rosen Law Firm, which is involved in the class action.
Jun 26, 2026 · 34 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States — Food and Drug Administration and Lawrence Rosen interact across events, view sentiment trends, and discover connected entities.
Open Dashboard